Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth

Abstract

The relevance of cysteine metabolism in cancer has gained considerable interest in recent years, largely focusing on its role in generating the antioxidant glutathione. Through metabolomic profiling using a combination of high-throughput liquid and gas chromatography–based mass spectrometry on a total of 69 patient-derived glioma specimens, this report documents the discovery of a parallel pathway involving cysteine catabolism that results in the accumulation of cysteine sulfinic acid (CSA) in glioblastoma. These studies identified CSA to rank as one of the top metabolites differentiating glioblastoma from low-grade glioma. There was strong intratumoral concordance of CSA levels with expression of its biosynthetic enzyme cysteine dioxygenase 1 (CDO1). Studies designed to determine the biologic consequence of this metabolic pathway identified its capacity to inhibit oxidative phosphorylation in glioblastoma cells, which was determined by decreased cellular respiration, decreased ATP production, and increased mitochondrial membrane potential following pathway activation. CSA-induced attenuation of oxidative phosphorylation was attributed to inhibition of the regulatory enzyme pyruvate dehydrogenase. Studies performed in vivo abrogating the CDO1/CSA axis using a lentiviral-mediated short hairpin RNA approach resulted in significant tumor growth inhibition in a glioblastoma mouse model, supporting the potential for this metabolic pathway to serve as a therapeutic target. Collectively, we identified a novel, targetable metabolic pathway involving cysteine catabolism contributing to the growth of aggressive high-grade gliomas. These findings serve as a framework for future investigations designed to more comprehensively determine the clinical application of this metabolic pathway and its contributory role in tumorigenesis.

Dynamic Thiol/Disulphide Homeostasis in Patients With Fibromyalgia

“…15,16 Abnormal thiol disulphide homeostasis states are involved in the pathogenesis of many kinds of diseases, including diabetes, 17 cardiovascular disease, 18 cancer, 19 chronic kidney disease, 20 and rheumatoid arthritis. 21 One side of this double-sided balance, namely thiols, has been measurable since 1979.…”

The Role of Thiol/Disulphide Homeostasis in Anthracycline Associated Cardiac Toxicity

“…11,12) Although thiol/disulfide homeostasis has been increasingly studied in many disorders, no studies thus far have investigated thiol/disulfide homeostasis in cancer patients who suffered from anthracycline-induced cardiotoxicity. 13,14) Thus, we aimed to evaluate whether thiol/disulfide homeostasis may plav a role in the protection of myocardial cells from anthracycline-induced toxicity as a novel oxidative stress parameter.…”

Bile acids regulate cysteine catabolism and glutathione regeneration to modulate hepatic sensitivity to oxidative injury

“…It is hypothesized that reduced CDO1 expression may provide an advantage to cancer cells to survive under an oxidative stress environment. However, a causative relationship has not been established so far, and the opposite effect of CDO1 expression in cancer cell growth has also been reported recently (47). A few studies conducted in genetic Cdo1-knockout mice revealed that whole-body complete CDO1 ablation caused more complex metabolic changes and subsequent pathological effects in mice.…”